Hepatitis B, C & D Viral Markers in Multitransfused Thalassemic Children: Long-term Complications and Present Management

Overview

Journal Indian J Pediatr

Specialty Pediatrics

Date 1995 Nov 1

PMID 10829940

Citations 4

Authors

V P Choudhry

S K Acharya

Affiliations

Soon will be listed here.

Citing Articles

Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Omata M, Kanda T, Yokosuka O, Crawford D, Al-Mahtab M, Wei L Hepatol Int. 2015; 9(4):486-507.

PMID: 25941137 DOI: 10.1007/s12072-015-9630-4.

Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Puri P, Anand A, Saraswat V, Acharya S, Dhiman R, Aggarwal R J Clin Exp Hepatol. 2015; 4(2):106-16.

PMID: 25755548 PMC: 4116733. DOI: 10.1016/j.jceh.2014.05.006.

Hepatitis B and C infections in multitransfused thalassemic patients.

Choudhry V Indian J Pediatr. 2015; 82(3):212-4.

PMID: 25669629 DOI: 10.1007/s12098-014-1676-0.

Past, present & future scenario of thalassaemic care & control in India.

Verma I, Saxena R, Kohli S Indian J Med Res. 2011; 134:507-21.

PMID: 22089615 PMC: 3237251.

References

Resti M, Azzari C, Rossi M, Vullo C, Zammarchi E, Vierucci A . Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis. Eur J Pediatr. 1992; 151(8):573-6. DOI: 10.1007/BF01957724. View

Shindo M, Di Bisceglie A, Cheung L, Shih J, Cristiano K, Feinstone S . Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med. 1991; 115(9):700-4. DOI: 10.7326/0003-4819-115-9-700. View

Lau Y, Chow C, Lee A, Ng K, Lim W, Chan C . Hepatitis C virus antibody in multiply transfused Chinese with thalassaemia major. Bone Marrow Transplant. 1993; 12 Suppl 1:26-8. View

Kaneko S, Miller R, Di Bisceglie A, Feinstone S, Hoofnagle J, Purcell R . Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis. Gastroenterology. 1990; 99(3):799-804. DOI: 10.1016/0016-5085(90)90971-3. View

Karayiannis P, Kanatakis S, Thomas H . Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment. J Hepatol. 1990; 10(3):350-2. DOI: 10.1016/0168-8278(90)90145-h. View

Yoo J, Howard R, WAGGONER J, Hoofnagle J . Peroxidase-anti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis. J Med Virol. 1987; 23(3):273-81. DOI: 10.1002/jmv.1890230310. View

Alexander G, Fagan E, Hegarty J, Yeo J, Eddleston A, Williams R . Controlled clinical trial of acyclovir in chronic hepatitis B virus infection. J Med Virol. 1987; 21(1):81-7. DOI: 10.1002/jmv.1890210111. View

Gulati S, Marwaha R, Dilawari J, Midha U, Walia B . Serological responses to hepatitis B virus infection in multi-transfused thalassemic children. Indian Pediatr. 1992; 29(1):73-7. View

Hurie M, Mast E, Davis J . Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees. Pediatrics. 1992; 89(2):269-73. View

10.

Clemente M, Congia M, Lai M, Lilliu F, Lampis R, Frau F . Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr. 1994; 125(1):123-8. DOI: 10.1016/s0022-3476(94)70138-5. View

11.

Perrillo R, Regenstein F, Bodicky C, Campbell C, Sanders G, Sunwoo Y . Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology. 1985; 88(3):780-6. DOI: 10.1016/0016-5085(85)90151-9. View

12.

Perrillo R, Mason A . Therapy for hepatitis B virus infection. Gastroenterol Clin North Am. 1994; 23(3):581-601. View

13.

Colombo M, Kuo G, Choo Q, Donato M, Del Ninno E, Tommasini M . Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989; 2(8670):1006-8. DOI: 10.1016/s0140-6736(89)91016-7. View

14.

Kiyosawa K, Akahane Y, Nagata A, Furuta S . Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol. 1984; 79(10):777-81. View

15.

Wonke B, Hoffbrand A, Brown D, Dusheiko G . Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. J Clin Pathol. 1990; 43(8):638-40. PMC: 502643. DOI: 10.1136/jcp.43.8.638. View

16.

Williams T, Wonke B, Donohue S . A study of hepatitis B and C prevalence and liver function in multiply transfused thalassemic and their parents. Indian Pediatr. 1992; 29(9):1119-24. View

17.

Peters M . Mechanisms of action of interferons. Semin Liver Dis. 1989; 9(4):235-9. DOI: 10.1055/s-2008-1040516. View

18.

Garson J, Tedder R, Briggs M, Tuke P, Glazebrook J, Trute A . Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet. 1990; 335(8703):1419-22. DOI: 10.1016/0140-6736(90)91446-h. View

19.

Hoofnagle J, Shafritz D, Popper H . Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology. 1987; 7(4):758-63. DOI: 10.1002/hep.1840070424. View

20.

Tong M, Sampliner R, Govindarajan S, Co R . Spontaneous reactivation of hepatitis B in Chinese patients with HBsAg-positive chronic active hepatitis. Hepatology. 1987; 7(4):713-8. DOI: 10.1002/hep.1840070416. View